Focus on Multiple Myeloma: Expert Insights and Strategies for Refining Patient Care

This comprehensive program gathers insight from 5 experts to improve the skills of clinicians who treat patients with multiple myeloma featuring education across the disease spectrum enhanced by practical tools for applying new findings in the clinic. All aspects of this program are designed to complement each other including an interactive treatment decision aid expert-authored modules expert commentaries a virtual presentation and downloadable slidesets.

Share

Program Content

Activities

Slides: Expert Insights and Strategies for ND MM
Focus on Newly Diagnosed Multiple Myeloma: Expert Insights and Strategies for Your Patients
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 03, 2017

Expires: May 02, 2018

Slides: Expert Insights and Strategies for RR MM
Focus on Multiple Myeloma: Expert Insights and Strategies for Refining Patient Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 16, 2017

Expires: June 15, 2018

Activities

CD38 Antibody Interference
How I Manage Laboratory Assay Interference With Anti-CD38 Antibodies in Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 17, 2016

Expires: October 16, 2017

Elderly Pts with R/R MM
My Treatment Approach for Very Elderly Patients With Multiple Comorbidities and Relapsed Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2016

Expires: December 12, 2017

Myeloma at 2016 Hematology Meeting
A Banner Year for Myeloma at the 2016 Hematology Meeting
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 27, 2016

Expires: December 26, 2017

New Agents for R/R Myeloma
How I Adapt My Clinical Practice to New Approaches for Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2017

Expires: January 22, 2018

Len Maintenance in MM
Lenalidomide Now Approved for Maintenance in Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2017

Expires: April 24, 2018

Triplet or Quad Therapy for MM?
Triplets and Quadruple Combination Therapy in Multiple Myeloma: When, Why, and How?
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 16, 2017

Expires: May 15, 2018

Activities

Slides: Focus on Myeloma
Focus on Multiple Myeloma: Expert Insights and Strategies for Refining Patient Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2017

Expires: July 31, 2018

Focus on Myeloma
Focus on Multiple Myeloma: Expert Insights and Strategies for Refining Patient Care
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2017

Expires: July 31, 2018

Faculty

cover img faculity

Kenneth Anderson, MD

Kraft Family Professor of Medicine
Harvard Medical School
Director, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Donna Catamero, ANP-BC, OCN, CCRC

Nurse Practitioner
Mount Sinai Hospital
New York, New York

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Celgene

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Takeda Oncology